Belite Bio (BLTE) Prepaid Assets (2021 - 2025)
Belite Bio (BLTE) recorded quarterly Prepaid Assets of $1.2 million in Q4 2025, down 27.81% quarter-over-quarter from $1.6 million in Q3 2025, and up 177.78% on a YoY basis from $414000.0 in Q4 2024.
Belite Bio (BLTE) Prepaid Assets (2021 - 2025) Analysis & Trends
Belite Bio's Prepaid Assets history runs 5 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 177.78% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 177.78% YoY), while the FY2025 annual figure was $1.2 million, up 177.78% from the prior year.
- Prepaid Assets was $1.2 million for Q4 2025 at Belite Bio, down from $1.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.6 million in Q3 2025 to a low of -$711000.0 in Q3 2024.
- Historically, Prepaid Assets has averaged $594142.9 across 5 years, with a median of $716000.0 in 2022.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 1332.0% in 2022, then tumbled 56.28% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $50000.0 in 2021, then jumped by 1332.0% to $716000.0 in 2022, then jumped by 32.26% to $947000.0 in 2023, then sank by 56.28% to $414000.0 in 2024, then surged by 177.78% to $1.2 million in 2025.
- The last three Prepaid Assets figures came in at $1.2 million (Q4 2025), $1.6 million (Q3 2025), and $414000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Dec 31, 2024 | 414,000.00 |
| Sep 30, 2024 | -711,000.00 |
| Dec 31, 2023 | 947,000.00 |
| Dec 31, 2022 | 716,000.00 |
| Dec 31, 2021 | 50,000.00 |